Sid Faces Selling Pressure Technical Levels To Watch 20260403 1 Can Kestra Kmts Stock Beat The Market Price At 19.32 Down 2.62 20260406 Is Progress Prgs Stock Overvalued Relative To Peers Prgs Q4 Earnings Beats Estimates By 0.00 20260408 1 Is Usa Rare Usar Stock Ready To Move Price At 15.31 Down 3.83 20260406 ARX Accelerant Holdings posts doubledigit Q4 2025 revenue growth and large earnings beat shares rise nearly 3 percent ONEOK Inc OKE Reports Q1 2026 Earnings Revenue Growth Solid Mixed Performance Across Business Segments How Bowhead BOW benefits from the shifts in its industry Runs Up 20260507 KMTS Kestra Medical Technologies Ltd rises 228 percent on 115 percent year over year Q1 2026 revenue growth Used Electric Vehicle Sales Surge in UK as Affordability Overtakes Range Concerns Phillips PECO Slides 113 as Selling Pressure Mounts 20260515 Digimarc DMRC Q1 2026 Earnings Beat Revenue NA EPS 007 Creator Content Takes Center Stage at TV Upfronts Reshaping Advertising Landscape SP 500 Moves Higher as Healthcare and Tech Rally Offsets Communication Services Weakness Plus500 Reports 11 Revenue Growth Reaffirms FullYear Outlook UKGCC Trade Deal Historic as Tariffs Scrapped on British Exports Memorial Day 2026 Stock Market Closure and Holiday Trading Schedule US Natural Gas Futures Decline as Forecasts Shift Warmer for Early February Tulsi Gabbard Steps Down as Trumps Intelligence Chief Amid Family Health Crisis Jobless Claims Remain Near Historic Lows Pointing to Continued Labor Market Resilience Coffee JVA shares climb 4 as 226 revenue growth offsets earnings miss surprising investors Is CohenSteers CNS stock struggling to move higher Cohen and Steers Inc misses EPS estimates by 34 ODDITY Tech Ltd ODD notches strong Q4 2025 EPS beat shares climb on positive investor sentiment OCCIO OFS Credit Company Inc 6125 Series C Term Preferred Stock posts 4387 negative Q1 2026 EPS surprise shares dip 052 The organic vs inorganic growth story at Robinhood Markets HOOD AEHR Aehr Test Systems shares jump 1042 percent after Q1 2026 EPS beats consensus estimates by 30 percent BGMS Bio Green Med Solution Inc reports sharp Q3 2024 revenue growth and narrower losses shares edge higher